Genpact Limited (NYSE:G – Get Free Report) has been given a consensus recommendation of “Hold” by the eight brokerages that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $38.63.
Several brokerages have issued reports on G. BMO Capital Markets upped their price target on shares of Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a report on Monday, August 12th. JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday. TD Cowen raised their price target on Genpact from $35.00 to $36.00 and gave the stock a “hold” rating in a research report on Friday, August 9th. Needham & Company LLC upped their price objective on Genpact from $40.00 to $42.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Wedbush reiterated a “neutral” rating and set a $35.00 price objective on shares of Genpact in a research report on Friday, May 10th.
View Our Latest Research Report on G
Institutional Inflows and Outflows
Genpact Stock Performance
Shares of G stock opened at $38.34 on Wednesday. The stock has a fifty day moving average price of $35.17 and a 200 day moving average price of $33.65. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.89 and a current ratio of 1.89. The stock has a market cap of $6.90 billion, a PE ratio of 10.95, a P/E/G ratio of 1.64 and a beta of 1.11. Genpact has a 1 year low of $29.41 and a 1 year high of $39.95.
Genpact (NYSE:G – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.05. Genpact had a return on equity of 22.28% and a net margin of 14.12%. The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.15 billion. Sell-side analysts forecast that Genpact will post 2.85 earnings per share for the current fiscal year.
Genpact Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 11th will be given a dividend of $0.1525 per share. The ex-dividend date of this dividend is Wednesday, September 11th. This represents a $0.61 annualized dividend and a yield of 1.59%. Genpact’s dividend payout ratio (DPR) is presently 17.43%.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories
- Five stocks we like better than Genpact
- Investing in Commodities: What Are They? How to Invest in Them
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- 10 Best Airline Stocks to Buy
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.